These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16261293)

  • 21. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of noninvasive hemoglobin monitoring in patients at risk for hemorrhage.
    Tsuei BJ; Hanseman DJ; Blakeman MJ; Blakeman TC; Yang SH; Branson RD; Gerlach TW
    J Trauma Acute Care Surg; 2014 Sep; 77(3 Suppl 2):S134-9. PubMed ID: 25159346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Warfarin exposure and the risk of thromboembolic and major bleeding events among medicaid patients with atrial fibrillation.
    Boulanger L; Hauch O; Friedman M; Foster T; Dixon D; Wygant G; Menzin J
    Ann Pharmacother; 2006 Jun; 40(6):1024-9. PubMed ID: 16735649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
    Hurlen M; Eikvar L; Seljeflot I; Arnesen H
    Thromb Res; 2006; 118(4):433-8. PubMed ID: 16139331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.
    Wallvik J; Själander A; Johansson L; Bjuhr O; Jansson JH
    Scand J Prim Health Care; 2007 Jun; 25(2):123-8. PubMed ID: 17497491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulation control and cost of monitoring of older patients on chronic warfarin therapy in three settings in North East England.
    Abohelaika S; Kamali F; Avery P; Robinson B; Kesteven P; Wynne H
    Age Ageing; 2014 Sep; 43(5):708-11. PubMed ID: 24947831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
    Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.
    White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S
    Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.
    Li G; Holbrook A; Delate T; Witt DM; Levine MA; Thabane L
    BMJ Open; 2015 Nov; 5(11):e009518. PubMed ID: 26546146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin for non-rheumatic atrial fibrillation: five year experience in a district general hospital.
    Yousef ZR; Tandy SC; Tudor V; Jishi F; Trent RJ; Watson DK; Cowell RP
    Heart; 2004 Nov; 90(11):1259-62. PubMed ID: 15486116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
    Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
    G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy.
    Lee JK; Kang HW; Kim SG; Kim JS; Jung HC
    Int J Clin Pract; 2012 Jan; 66(1):64-8. PubMed ID: 22171905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study.
    Iwabuchi H; Imai Y; Asanami S; Shirakawa M; Yamane GY; Ogiuchi H; Kurashina K; Miyata M; Nakao H; Imai H
    BMJ Open; 2014 Dec; 4(12):e005777. PubMed ID: 25510886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy.
    Yang FE; Vaida F; Ignacio L; Houghton A; Nauityal J; Halpern H; Sutton H; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):617-17. PubMed ID: 7558950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative.
    Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT
    Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.